What question did this study set out to answer?

To evaluate the incidence and clinical distribution of PD-1 inhibitor-related pneumonitis among patients undergoing treatment for advanced cancer.

August 19, 2016JAMA OncologyOpen Access

Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer

View Full Paper

Ask AI

Bookmark

Authors

MNMizuki NishinoBrigham and Women's Hospital AGAnita Giobbie‐HurderDana-Farber Cancer Institute HHHiroto HatabuSprint (United States)

Discussion

Member takes

Implication

Clinical study reports higher incidence of PD-1 inhibitor-related pneumonitis in NSCLC, RCC, and combination therapy, highlighting the need for vigilance.

Key Points

To evaluate the incidence and clinical distribution of PD-1 inhibitor-related pneumonitis among patients undergoing treatment for advanced cancer.
Assessed rates of treatment-related pneumonitis across different tumor types and treatment strategies in patients with advanced cancer receiving PD-1 inhibitors.
Identified an increased incidence of PD-1 inhibitor-related pneumonitis in patients with non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC).
Observed higher rates of pneumonitis when PD-1 inhibitors were administered in combination therapy regimens compared to monotherapy.

Cite This Study

Nishino et al. (2016) studied this question.

synapsesocial.com/papers/69d8f56233ca018b39ae45ca https://doi.org/10.1001/jamaoncol.2016.2453

View Full Paper

Ask AI

Bookmark

Implication

Clinical study reports higher incidence of PD-1 inhibitor-related pneumonitis in NSCLC, RCC, and combination therapy, highlighting the need for vigilance.

Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider